OncoTracker
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
9201 W Sunset Blvd Ste 300, West Hollywo...Phone Number
(424) 204-0734Website
www.oncotracker.comRevenue
$5.5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About OncoTracker
ONCOtracker is a leading innovation center specializing in cancer treatment and testing, particularly for multiple myeloma and other B-cell malignancies. The company offers exclusive clinically validated ELISA sBCMA testing services, myeloma patient-derived tumor cell lines for drug discovery, and maintains a large onsite biobank for related research. Founded by Dr. James R. Berenson, a prominent researcher in multiple myeloma, ONCOtracker focuses on precision medicine and developing innovative therapies to enhance patient outcomes. Their services are aimed at clinical and research institutions looking to enhance drug evaluation and treatment options for cancer patients.Explore more
OncoTracker Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OncoTracker your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when OncoTracker launches new products
Congratulate Masked Content for being promoted to Masked Content at OncoTracker
Funding: Get notified immidiatlly once OncoTracker has new funding data
OncoTracker, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if OncoTracker had a recent Job posting/layoffs
Check if OncoTracker has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if OncoTracker is spiking on competitors!
Earning: See what the market has to say on OncoTracker recently announced quarterly report
Recommended Actions
Find VP level buyers at OncoTracker
Find 3 more new buyers
Compare Similar Companies to OncoTracker
Compare insights from companies similar to OncoTracker, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
OncoTracker is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
OncoTracker is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about OncoTracker.
OncoTracker Tech Stack
A closer look at the technologies used by OncoTracker
See more technologies
OncoTracker News & Media
OncoTracker CEO to Speak at 20th Annual SoCalBio Conference
WEST HOLLYWOOD, Calif., Sept. 24, 2018 /PRNewswire/ -- OncoTracker, Inc. announced that its Chief Executive Officer, James Kuo, MD, MBA, has been invited to speak at the 20th Annual SoCalBio Conference taking place on Friday, September 28, 2018. Dr. Kuo will provide an update on...OncoTracker Appoints James Kuo as CEO
WEST HOLLYWOOD, Calif., Aug. 20, 2018 /PRNewswire/ -- OncoTracker, Inc. announced the appointment of James Kuo, MD, MBA, as its Chief Executive Officer. Dr. Kuo is a biotech executive with more than 20 years of experience in corporate development, finance and licensing. Previously, Dr....Juno Therapeutics Signs Licensing Agreements with Lilly, OncoTracker, and Fred Hutchinson Cancer Research Center to Advance Its BCMA-Directed Engineered T Cell Program in Multiple Myeloma with Gamma Secretase Inhibition
SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ: JUNO), a biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer, today announced three license agreements to advance its program in multiple myeloma using gamma secretase inhibitors (GSIs) in combination with BCMA-directed CAR T cells. Gamma secretase is an enzyme that cleaves a set of transmembrane proteins, including BCMA. Multiple publications have shown that treatment with GSIs can incre
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OncoTracker
Sign Up For FreeTo access detailed company insights
ONCOtracker is a leading innovation center specializing in cancer treatment and testing, particularly for multiple myeloma and other B-cell malignancies. The company offers exclusive clinically validated ELISA sBCMA testing services, myeloma patient-derived tumor cell lines for drug discovery, and maintains a large onsite biobank for related resear... Read More
